Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C

BACKGROUND: An estimated 170 million individuals worldwide are infected with the hepatitis C virus (HCV). Although treatment options using a combination of pegylated interferon and ribavirin (P-IFN/RBV) are available, sustained clearance of the virus is only achieved in approximately 40% of individu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Ther Res Clin Exp
Main Authors: Zaily, Dorta Guridi, Marlen, Castellanos Fernandez, Santiago, Dueñas-Carrera, Gillian, Martínez Donato, Carmen, Valenzuela Silva, Zurina, Cinza Estevez, Enrique R., Arús Soler, Liz, Alvarez-Lajonchere, Lisset, González Fabián, Sacha, Lazo del Vallín, Elena, Ferrer Bataille
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5681293/
https://ncbi.nlm.nih.gov/pubmed/29158855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2017.04.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados